Related Experiment Video
Updated: Dec 18, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Inflammation shapes pathogenesis of murine arrhythmogenic cardiomyopathy
Nadine Lubos1, Svenja van der Gaag1, Muhammed Gerçek1
1Institute of Molecular and Cellular Anatomy, RWTH Aachen University, 52074, Aachen, Germany.
Insights
Inflammation drives arrhythmogenic cardiomyopathy (AC) progression. Immune cells like neutrophils, macrophages, and T cells, along with specific chemokines, play key roles in AC pathogenesis and scar development.
Area of Science:
- Cardiovascular Research
- Immunology
- Genetic Diseases
Background:
- Arrhythmogenic cardiomyopathy (AC) is an incurable genetic heart disease characterized by arrhythmia, fibrosis, and dilation, often leading to sudden cardiac death or heart failure.
- The precise pathogenesis of AC remains poorly understood, necessitating the development of effective therapeutic strategies.
- Desmoglein 2 (DSG2) mutations are linked to human AC, and DSG2 auto-antibodies are found in patients, making DSG2-related mouse models crucial for research.
Purpose of the Study:
- To investigate the role of inflammation in the pathogenesis of arrhythmogenic cardiomyopathy (AC).
- To elucidate the specific immune cell populations and chemokine profiles involved in AC progression.
- To explore potential therapeutic targets by understanding the inflammatory mechanisms in AC.
Main Methods:
- Utilized two mouse strains: one with mutant desmoglein 2 (DSG2) and another lacking DSG2 in cardiomyocytes.
- Analyzed inflammatory responses, including cardiomyocyte necrosis, immune cell infiltration (neutrophils, macrophages, T cells), and chemokine expression (Ccl2/Ccr2, Ccl3/Ccr5, Cxcl5/Cxcr2, Cx3cl1/Cx3cr1, Cxcl10/Cxcr3).
- Examined scar formation and progression from cellular to collagen-rich structures during acute and chronic disease phases.
Main Results:
- Multifocal cardiomyocyte necrosis initiated neutrophil-dominated inflammation, involving macrophages and T cells.
- Acute phase showed accumulation of Mmp12+ and Spp1+ macrophages and T cells in developing scars, with dominant chemokine expression of Cx3cl1/Cx3cr1, Ccl2/Ccr2, and Cxcl10/Cxcr3.
- Chronic phase revealed persistent macrophages and T cells in mature scars and expanding fibrosis, with Ccl12 and Cx3cl1 as predominant chemokines.
Conclusions:
- Inflammation, driven by specific immune cell populations and chemokine signaling, is a major component of arrhythmogenic cardiomyopathy pathogenesis.
- Immune cell dynamics and chemokine expression profiles evolve throughout AC progression, influencing inflammatory and repair processes.
- These findings highlight the potential of targeting inflammatory pathways and immune cell interactions for AC treatment.
Abstract:
Arrhythmogenic cardiomyopathy (AC) is an incurable genetic disease, whose pathogenesis is poorly understood. AC is characterized by arrhythmia, fibrosis, and cardiodilation that may lead to sudden cardiac death or heart failure. To elucidate AC pathogenesis and to design possible treatment strategies of AC, multiple murine models have been established. Among them, mice carrying desmoglein 2 mutations are particularly valuable given the identification of desmoglein 2 mutations in human AC and the detection of desmoglein 2 auto-antibodies in AC patients. Using two mouse strains producing either a mutant desmoglein 2 or lacking desmoglein 2 in cardiomyocytes, we test the hypothesis that inflammation is a major component of disease pathogenesis. We show that multifocal cardiomyocyte necrosis initiates a neutrophil-dominated inflammatory response, which also involves macrophages and T cells. Increased expression of Ccl2/Ccr2, Ccl3/Ccr5, and Cxcl5/Cxcr2 mRNA reflects the observed immune cell recruitment. During the ensuing acute disease phase, Mmp12+ and Spp1+ macrophages and T cells accumulate in scars, which mature from cell- to collagen-rich. The expression of Cx3cl1/Cx3cr1, Ccl2/Ccr2, and Cxcl10/Cxcr3 dominates this disease phase. We furthermore find that during chronic disease progression macrophages and T cells persist within mature scars and are present in expanding interstitial fibrosis. Ccl12 and Cx3cl1 are predominant chemokines in this disease phase. Together, our observations provide strong evidence that specific immune cell populations and chemokine expression profiles modulate inflammatory and repair processes throughout AC progression.
More Related Videos
08:38Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery
Published on: August 16, 2019
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Related Concept Videos
Myocarditis I: Introduction
Cardiomyopathy I: Introduction and Classification
Rheumatic Heart Disease I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Mechanism of Cardiac Arrhythmias
Myocarditis II: Clinical Features and Diagnostic Tests